Native vs. active vitamin D for children with chronic kidney disease: a cross-over study

Native vs. active vitamin D for children with chronic kidney disease: a cross-over study - Native vs. active vitamin D for children with chronic kidney disease: a cross-over study: native vs. active vitamin D for CKD children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039891

Enrollment

Registered

2020-03-22

Start date

2019-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cross-over study

Interventions

native vitamin D (cholecalciferol) Active vitamin D (alfacalcidol)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic kidney disease children stages 2-5 (pre-dialysis)

Exclusion criteria

Exclusion criteria: - CKD stage 5 on dialysis - Baseline serum 25(OH)D 3level more than 30 ng/ml or baseline hypo- or hypercalcemia (serum calcium less than 8 or more than 11 mg/dl, respectively).

Design outcomes

Primary

Measure	Time frame
mean change of 25(OH)D3 after treatment	—

Countries

Africa

Contacts

Public ContactHappy Sawires

Cairo University Faculty of Medicine

happy7_kd@yahoo.com+201005446448

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026